| Literature DB >> 30564531 |
Narcisse O Amine1, Christine M Lomiguen2, Asma Iftikhar3, Sonu Sahni4.
Abstract
Spontaneous pneumomediastinum (SPM), also referred to as mediastinal emphysema, is defined as the presence of free air in the mediastinal cavity without a clear and identifiable cause. Spontaneous pneumomediastinum, in general, is a relatively rare condition, more so in the setting of pregnancy or labor. Clinically, SPM may present as dyspnea, chest pain, and subcutaneous swelling, which may be of serious concern in the setting of pregnancy. A comprehensive literature review revealed that the majority of patients are primiparas, of a younger age, and have term or longer durations of pregnancy. The second stage of labor was found to be most commonly associated with the development of SPM. The pathomechanism suggests that performing the Valsalva maneuver during the active stages of labor may play a role in the development of SPM. Once diagnosed, patients with SPM in pregnancy are admitted to the hospital, treated conservatively, and followed until resolution. SPM must be diagnosed and managed promptly due to rare but serious complications. In addition, dyspnea or chest pain with an unknown etiology should include SPM in the differential diagnosis, especially in the setting of pregnancy and labor.Entities:
Keywords: chest pain; dyspnea; labor; pneumomediastinum; pregnancy; spontaneous pneumomediastinum; subcutaneous emphysema
Year: 2018 PMID: 30564531 PMCID: PMC6298626 DOI: 10.7759/cureus.3452
Source DB: PubMed Journal: Cureus ISSN: 2168-8184
Figure 1Chest X-ray showing the presence of pneumomediastinum
Red arrows point to free air around the heart silhouette.
Figure 2Computer tomography showing the presence of free air in the mediastinum anterior to the heart and great vessels
Red arrows point to the pockets of free air in the mediastinal cavity.
Figure 3The proposed pathophysiologic process of spontaneous pneumomediastinum in pregnancy
Summary of spontaneous pneumomediastinum cases in pregnancy
| Author | Age | Parity | Stage of Labor | Duration of Labor (hours) | Duration of Pregnancy (weeks) | Treatment |
|
Crean et al. 1981 [ | 22 y/o | 1st | 2nd stage | 12 | N/A | Oxygen |
|
Hubbert et al. 1981 [ | 17 y/o | N/A | 2nd stage | N/A | N/A | Oxygen, fentanyl, diazepam, & succinycholine |
| 18 y/o | N/A | 2nd stage | N/A | N/A | Oxygen | |
|
Karson et al. 1984 [ | 20 y/o | 1st | 1st stage | N/A | 9 | Pyridoxine 2x daily |
| 20 y/o | 1st | 1st stage | N/A | 42 | None | |
|
Jensen et al. 1987 [ | 24 y/o | 1st | 2nd stage | 10.5 | 41 | Oxygen |
| Ramirez-Rivera et al. 1990 [16] | 15 y/o | 1ST | 2nd stage | 14 | N/A | Oxygen |
| Jayran-Nejad et al. 1993 [17] | 18 y/o | 1st | 2nd stage | 15.6 | 42 | Analgesia |
|
Seidl et al. 1994 [ | 23 y/o | 2nd | N/A | N/A | 42 | None |
| Gocmen et al. 1997 [19] | 17 y/o | 1st | N/A | 11 | 39 | Symptomatic management & monitoring |
| Shyamsunder et al. 1999 [20] | 18 y/o | 2nd | 2nd stage | N/A | 6 | None |
| Gorbach et al. 1997 [21] | 21 y/o | N/A | 2nd stage | 4 | 9 | IV Fluids, Promethazine |
|
Raley et al. 1997 [ | N/A | N/A | N/A | N/A | 41 | Oxygen |
| Dhrampal et al. 2001 [23] | 36 y/o | N/A | 2nd stage | N/A | 37 | Oxygen & analgesia |
|
Sutherland et al. 2002 [ | 32 y/o | 1st | 2nd stage | 8 | N/A | None |
| 22 y/o | 1st | 2nd stage | 13 | N/A | None | |
| Miguil et al. 2004 [25] | 19 y/o | N/A | 2nd stage | N/A | 40 | Oxygen & analgesia |
|
Balkan et al. 2006 [ | 25 y/o | 1st | 2nd stage | N/A | 36 | Oxygen |
|
Bonin et al. 2006 [ | 27 y/o | 1st | 2nd stage | 6 | 38 | Lorazepam for anxiety; anxiolytics for dyspnea |
| North et al. 2006 [27] | 32 y/o | N/A | 2nd | N/A | N/A | Laxatives |
| Yadav et al. 2008 [28] | 21 y/o | 1st | 2nd stage | 1.3 | N/A | Oxygen & analgesics |
|
Mahboob et al. 2008 [ | 24 y/o | N/A | 2nd stage | N/A | 39 | Oral antibiotics |
| Zapardiel et al. 2009 [29] | 29 y/o | 1st | 4th stage – only time | 7 | 39 | Oxygen |
|
Speksnijder et al. 2010 [ | 15 y/o | N/A | 2nd stage | N/A | 28 | Insulin, fluid, & potassium supplementation |
|
Beynon et al. 2011 [ | 18 y/o | 1st | 2nd stage | 4.3 | 39 + 2 | Antibiotics & analgesia |
| Wozniak et al. 2011 [32] | 20 y/o | N/A | 2nd stage | N/A | 41 | Observation |
|
Shrestha et al. 2011 [ | 19 y/o | 1st | 2nd stage | N/A | 36 | None |
|
Kuruba et al. 2011 [ | 32 y/o | 2nd | 2nd stage | 1.5 | 40 | None |
| McGregor et al. 2011 [35] | 27 y/o | 1st | 2nd stage | 1.5 | 40 | Oxygen & analgesia |
|
Khoo et al. 2012 [ | 33 y/o | 1st | 2nd stage | 12 | 40 | Analgesia & best rest |
|
Kouki et al. 2013 [ | 23 y/o | 1st | 2nd stage | 9 | 40 | Oxygen & analgesics and sedatives |
|
Cho et al. 2015 [ | 28 y/o | 1ST | 2nd stage | 5 | 36 | Oxygen & analgesics |
|
Scala et al. 2016 [ | 30 y/o | N/A | N/A | N/A | 40 | None |
| Nagarajan et al. 2017 [40] | 30 y/o | N/A | 2nd stage | N/A | 41 | Observation |
|
Berdai et al. 2017 [ | 22 y/o | 1ST | 2nd stage | 2H | 40 | Oxygen |
Clinical signs and symptoms of pregnancy-associated SPM
SPM: spontaneous pneumomediastinum
| Signs & Symptoms | Number of Cases (%) |
| Swelling & Subcutaneous Emphysema (face, neck, etc.) | 21 (60.0) |
| Dyspnea | 16 (45.7) |
| Chest Pain | 13 (37.1) |
| Crepitus | 10 (28.6) |
| Tachycardia | 7 (20.0) |
| Vomiting | 5 (14.3) |
| Cough | 3 (8.6) |
Figure 4Diagnostic and management algorithm of SPM in pregnancy
SPM: spontaneous pneumomediastinum